Share this article on:

Challenges in Estimating Efficacy Against Pneumococcal Pneumonia in Children

Black, Steven MD

The Pediatric Infectious Disease Journal: April 2012 - Volume 31 - Issue 4 - p 426
doi: 10.1097/INF.0b013e318245dee0
Letters to the Editor

Center for Global Health, Cincinnati Children’s Hospital, Cincinnati, OH

K.J.C. and P.R.P. are current employees of Pfizer and were previously employed by Wyeth Pharmaceuticals, now a wholly owned subsidiary of Pfizer. The authors have no other funding or conflicts of interest to disclose.

The author receives compensation from Novartis Vaccines for consulting. The author has no other funding or conflicts of interest to disclose.

© 2012 Lippincott Williams & Wilkins, Inc.